glp-1 australia Mel Scott | Have you ever heard of GLP-1? We are launching in Australia, New Zealand and the USA! It's this awesome hormone that does so many things New GLP-1 agonist guidance FAQs

Therefore, practitioners should exercise caution when considering combination approaches, particularly for patients with existing cardiovascular risk factors

The contents do not represent the views of the US Department of Veterans Affairs or the US government

With the accelerated adoption of GLP-1s, contract development and manufacturing organizations (CDMOs) have become essential strategic partners for navigating the evolving landscape

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

This is telogen effluvium, and it's the same type of hair loss seen after major surgery, severe illness, crash dieting, and childbirth

A retrospective cohort study found that semaglutide use was associated with a 44% reduced risk of incident cannabis use disorder (CUD) in patients with no prior history (hazard ratio [HR]: 0.56, 95% confidence interval [CI]: 0.420.75) and a 38% reduction in recurrent CUD diagnosis (HR: 0.62, 95% CI: 0.460.84) among patients with a prior history, compared to non-GLP-1RA medications [61]